EFFICACY AND SAFETY OF ROFLUMILAST CREAM 0.15% IN ADULTS AND CHILDREN AGED 6 AND OLDER WITH MILD TO MODERATE ATOPIC DERMATITIS IN TWO PHASE 3 INTEGUMENT TRIALS

被引：0
|
作者：
Simpson, E. [1 ]
Eichenfield, L. F. [2 ,3 ]
Gooderham, M. [4 ,5 ]
Gonzalez, M. [6 ]
Hebert, A. A. [7 ]
Papp, K. A. [8 ]
Prajapati, V [9 ,10 ]
Krupa, D. [11 ]
Burnett, P. [11 ]
Berk, D. R. [11 ]
Higham, R. [11 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Rady Childrens Hosp, San Diego, CA 92103 USA
[4] Prob Med Res, SKiN Ctr Dermatol, Peterborough, ON, Canada
[5] Queens Univ, Peterborough, ON, Canada
[6] Pediat Skin Res LLC, Miami, FL USA
[7] UT Hlth McGovern Med Sch, Houston, TX USA
[8] Prob Med Res & Alliance Clin Res, Waterloo, ON, Canada
[9] Univ Calgary, Dermatol Res Inst, Skin Hlth & Wellness Ctr, Calgary, AB, Canada
[10] Prob Med Res, Calgary, AB, Canada
[11] Arcutis Biotherapeut Inc, Westlake Village, CA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO136
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials
    Katoh, N.
    Kataoka, Y.
    Saeki, H.
    Hide, M.
    Kabashima, K.
    Etoh, T.
    Igarashi, A.
    Imafuku, S.
    Kawashima, M.
    Ohtsuki, M.
    Fujita, H.
    Arima, K.
    Takagi, H.
    Chen, Z.
    Shumel, B.
    Ardeleanu, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : 39 - 51
  • [42] EFFICACY AND SAFETY OF CRISABOROLE IN PATIENTS ≥3 MONTHS OF AGE WITH MILD-TO-MODERATE ATOPIC DERMATITIS (AD)
    Su, John C.
    Spelman, Lynda J.
    Eichenfield, Lawrence F.
    Gold, Linda F. Stein
    Cha, Amy
    Graham, Daniela
    Takiya, Liza
    Werth, John L.
    Zang, Chuanbo
    Vlahos, Bonnie
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 55 - 56
  • [43] Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with moderate and/or more extensive atopic dermatitis: subgroup analysis from the TRuE-AD3 study
    Eichenfield, Lawrence F.
    Armstrong, April W.
    Gold, Linda F. Stein
    Zaenglein, Andrea L.
    Lee, Lara Wine
    Brar, Kanwaljit K.
    Joyce, Joel C.
    Holland, Kristen E.
    Angel, Brett
    Sturm, Daniel
    Li, Qian
    Simpson, Eric L.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [44] Efficacy of a Cosmetic Treatment in Decreasing the Mild-to-Moderate Atopic Dermatitis in Babies, Children, and Adults: A Pilot Study
    Nobile, Vincenzo
    Zanoletti, Valentina
    Pisati, Marta
    Cestone, Enza
    COSMETICS, 2023, 10 (04)
  • [45] Long-term safety of Crisaborole Topical Ointment, 2%, in children and adults with mild to -moderate atopic dermatitis
    Zane, Lee Thomas
    Eichenfield, Lawrence F.
    Call, Robert S.
    Forsha, Douglass W.
    Fowler, Joseph F.
    Hebert, Adelaide A.
    Spellman, Mary
    Gold, Linda F. Stein
    Van Syoc, Merrie
    Tschen, Eduardo H.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [46] Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis The Phase 3 ECZTRA 6 Randomized Clinical Trial
    Paller, Amy S.
    Flohr, Carsten
    Cork, Michael
    Bewley, Anthony
    Blauvelt, Andrew
    Hong, H. Chih-ho
    Imafuku, Shinichi
    Schuttelaar, Marie L. A.
    Simpson, Eric L.
    Soong, Weily
    Arlert, Petra
    Lophaven, Katja Wendicke
    Kurbasic, Azra
    Soldbro, Lise
    Vest, Natacha Strange
    Wollenberg, Andreas
    JAMA DERMATOLOGY, 2023, 159 (06) : 596 - 605
  • [47] Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children
    Simpson, Eric L.
    Hebert, Adelaide A.
    Browning, John
    Serrao, Rocco T.
    Sofen, Howard
    Brown, Philip M.
    Piscitelli, Stephen C.
    Rubenstein, David S.
    Tallman, Anna M.
    DERMATOLOGY AND THERAPY, 2025, 15 (01) : 111 - 124
  • [48] Efficacy and safety of BSZY cream for mild-to-moderate atopic facial dermatitis: protocol of a randomised, double-blind, controlled trial
    Wang, Peiyao
    Wei, Xuqiang
    Cheng, Linyan
    Guo, Dongjie
    Du, Ting
    Guo, Wanjun
    Xi, Ruofan
    Duan, Yanjuan
    Liu, Xin
    Wang, Yi
    Lu, Hanzhi
    Yan, Ge
    Zhu, Jianyong
    Hua, Liang
    Li, Fulun
    BMJ OPEN, 2025, 15 (03):
  • [49] Randomized, controlled, double-blind clinical study evaluating the safety and efficacy of MD2011001 cream in mild-to-moderate atopic dermatitis of the face and neck in children, adolescents and adults
    Patrizi, Annalisa
    Raone, Beatrice
    Neri, Iria
    Gurioli, Carlotta
    Carbonara, Monica
    Cassano, Nicoletta
    Vena, Gino Antonio
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (04) : 346 - 350
  • [50] Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3
    Blauvelt, Andrew
    Gooderham, Melinda
    Bhatia, Neal
    Langley, Richard G.
    Schneider, Shannon
    Zoidis, John
    Kurbasic, Azra
    Armstrong, April
    Silverberg, Jonathan, I
    DERMATOLOGY AND THERAPY, 2022, 12 (11) : 2499 - 2516
12345